Alkermes plc today announced the presentation of accepted research at key scientific conferences this spring related to its psychiatry products?LYBALVI® (olanzapine and samidorphan) and ARISTADA® ...

Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut Takeda Pharmaceutical (NYSE:TAK) reported fiscal 2025 results that management described as solid despite pressure from generic ...

Over the last ten years, several global investigations and recoveries from war zones have suggested that Captagon was widely ...

Alkermes has reached an agreement to buy Avadel Pharma in a deal valued at up to $2.1 billion, claiming rights to an FDA-approved therapy for sleep disorder narcolepsy that has been predicted to make ...

These LGBTQ movies are inspiring, thought-provoking, romantic, funny and just plain fun ...

Two discoveries -- one in the brains of people with heroin addiction and the other in the brains of sleepy mice -- shed light on chemical messengers in the brain that regulate sleep and addiction. Two ...

Type 2 narcolepsy features excessive daytime sleepiness (EDS) without cataplexy — the sudden loss of muscle tone triggered by emotions that defines type 1. Symptoms are generally milder than type 1.

Even though we live in a culture where social media gives anyone and everyone a platform to broadcast their inner lives, people today are astonishingly un-self-aware. Though 95% of people believe they ...

Whether your symptoms are mild or severe, there’s no question that narcolepsy can interfere with your daily life. This neurological disorder can cause daytime sleepiness as well as hallucinations and ...

The etiology of the sleep disorder narcolepsy has not been firmly established, although an autoimmune pathogenesis has been proposed and is supported by a strong genetic association with the HLA. A ...

Narcolepsy is a chronic neurological disorder characterised by excessive daytime sleepiness and, in type 1 cases, cataplexy resulting from selective loss of hypothalamic hypocretin (orexin) neurons.